Home Business Wall Street Weekly: Stocks Fall Amid Policy Uncertainty, Middle East Tensions

Wall Street Weekly: Stocks Fall Amid Policy Uncertainty, Middle East Tensions

Share
wall-street-weekly:-stocks-fall-amid-policy-uncertainty,-middle-east-tensions
Wall Street Weekly: Stocks Fall Amid Policy Uncertainty, Middle East Tensions
Share
Panos Mourdoukoutas

Panos Mourdoukoutas

Author

Panos Mourdoukoutas is a professor of economics at Long Island University in New York City. He also teaches security analysis at Columbia University. He’s been published in professional journals and magazines, including Forbes, Investopedia, Barron’s, IBT, and Journal of Financial Research. He’s also the author of many books, including “Business Strategy in a Semiglobal Economy” and “China’s Challenge.”

Author’s Selected Articles

Darden Restaurants Sales Rise Despite Concerns Over Consumer Spending Slowdown

Darden Restaurants Sales Rise Despite Concerns Over Consumer Spending Slowdown

Lennar Sells More Homes at Lower Prices Amid Soft Housing Market

Lennar Sells More Homes at Lower Prices Amid Soft Housing Market

RH Plans to Move Production From China to US and Italy

RH Plans to Move Production From China to US and Italy

Wall Street Review: Stocks Pause on Mideast Tensions, Fed Decision Ahead

Wall Street Review: Stocks Pause on Mideast Tensions, Fed Decision Ahead
Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...